Diagnostics of autoimmune neurodegeneration using fluorescent probing - Wikidata - wikimedia - TriplyDB

Diagnostics of autoimmune neurodegeneration using fluorescent probing

Diagnostics of autoimmune neurodegeneration using fluorescent probing

http://www.wikidata.org/entity/Q58714753

about

Diagnostics of autoimmune neurodegeneration using fluorescent probing

http://www.wikidata.org/entity/Q58714753

description

article publié dans la revue scientifique Scientific Reports

@fr

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Diagnostics of autoimmune neurodegeneration using fluorescent probing

@en

Diagnostics of autoimmune neurodegeneration using fluorescent probing

@nl

type

label

Diagnostics of autoimmune neurodegeneration using fluorescent probing

@en

Diagnostics of autoimmune neurodegeneration using fluorescent probing

@nl

prefLabel

Diagnostics of autoimmune neurodegeneration using fluorescent probing

@en

Diagnostics of autoimmune neurodegeneration using fluorescent probing

@nl

P1433

Q58714753-785FB1E9-EC7B-41EB-BE11-F4413622BBF0

P1476

Q58714753-C16AE4C7-4866-4986-8A3B-C049D073D883

P2093

Q58714753-0A6B4B91-97A5-47A4-BFAC-1181C7B75787

Q58714753-2C1C2B13-363F-4233-98AF-C3D1C2BA4245

Q58714753-2D2F0552-43A4-4EF1-A46B-FDB83F596D0F

Q58714753-643005A6-0D95-4356-9942-97A9C6FB71C8

Q58714753-79199819-7A29-47E5-8440-80A1FC6BCFE2

Q58714753-99DCFCAB-4065-420E-9273-4875846C120E

Q58714753-A8A3360E-24BE-4C1B-A68F-C84F4CE1D66F

Q58714753-C104FBEC-B475-4584-AD27-CCBC07FE57AF

Q58714753-D0FCB9B7-06C8-4885-8044-C81CB47B4F46

P2860

Q58714753-01BC50C4-A2D0-4309-A7F7-54396EB0697C

Q58714753-0366EFFF-8E37-4DA1-8DD6-CE0141CD9F93

Q58714753-0CDCAA40-F53F-4E53-A072-4C83EA612C1E

Q58714753-0EE87675-F1D3-4030-A3CF-1BDD11557423

Q58714753-1478C690-45D3-4E91-B4D9-DB115EE4BA22

Q58714753-270DEDA3-F1DB-498B-9197-334036784F7B

Q58714753-331E6C95-72AA-4188-BE81-A7FCF78E0A63

Q58714753-349861FD-480B-4DC5-BDEC-D6D27EBCB287

Q58714753-35F9C7C2-63E0-41EF-B608-526E5DDED4CA

Q58714753-3F30692E-435F-454D-9A91-F9F94BB3BEDE

P2888

Q58714753-F1617668-EF8F-4E58-BB95-C5C99FE69410

P304

Q58714753-9ACC5978-115D-46EB-ADEA-CA80ED23D2D9

P31

Q58714753-2C3F6A47-3E87-4692-B1D3-D9EF86C008EB

P356

Q58714753-F80B5E70-ECF4-4F0B-96B1-366AAA16E2EC

P407

Q58714753-5B2EED74-A566-477B-B8EA-F3710F87BA4E

P433

Q58714753-8E8F86D2-6DB8-4696-A2E6-1CA827E88875

P478

Q58714753-4E1D7C74-E7E3-43C9-BC92-58C2D8987AA2

P50

Q58714753-4A0A7765-B98D-4576-ADC4-C963912C4E03

Q58714753-9E93E791-5478-4892-892E-9103483A0D2E

Q58714753-FB27BA75-6E52-4A3A-A269-1B77E8D12324

P577

Q58714753-E1F8CDD8-A108-47B1-BD3C-8B2FA90503DA

P6179

Q58714753-1A5CABE2-E179-4ECF-869D-D21A86A5F049

P698

Q58714753-FB24A0A5-C712-4EA2-9EBC-5438DB46506E

P932

Q58714753-6700C60A-BA0B-4AA3-97E2-23706735D498

P356

S41598-018-30938-0

P1433

Scientific Reports

P1476

Diagnostics of autoimmune neurodegeneration using fluorescent probing

@en

P2093

Alena Kaminskaya

http://www.w3.org/2001/XMLSchema#string

Alexander Chernov

http://www.w3.org/2001/XMLSchema#string

Alexander Gabibov

http://www.w3.org/2001/XMLSchema#string

Anna Kudriaeva

http://www.w3.org/2001/XMLSchema#string

Georgy Telegin

http://www.w3.org/2001/XMLSchema#string

Maria Zakharova

http://www.w3.org/2001/XMLSchema#string

Stanislav Terekhov

http://www.w3.org/2001/XMLSchema#string

Taras Simaniv

http://www.w3.org/2001/XMLSchema#string

Yakov Lomakin

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.

High levels of catalytic antibodies correlate with favorable outcome in sepsis.

DNA hydrolyzing autoantibodies.

Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis

Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.

Systemic lupus erythematosus: molecular cloning and analysis of 22 individual recombinant monoclonal kappa light chains specifically hydrolyzing human myelin basic protein.

P2888

s41598-018-30938-0

P304

12679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-30938-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Alexey Belogurov

P577

2018-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106199575

http://www.w3.org/2001/XMLSchema#string

P698

30139963

http://www.w3.org/2001/XMLSchema#string

P932

6107501

http://www.w3.org/2001/XMLSchema#string